Notably, other researchers who used mouse BC models also reported a reduced expression of checkpoint molecules on immune cells upon CDK4/6 inhibitor therapy [66,67]; however, they associated this finding with less T cell exhaustion. The gene discussed is CDK4; the disease is breast cancer.